Shu-Jen Chen

Company: AnHorn Medicines

Job title: Chief Scientific Officer

Seminars:

Discovering New Moieties to Recruit Other E3 Ubiquitin Ligases 4:10 pm

• Sharing AI-enhanced discovery pipeline for targeted protein degradation • Discussing development of a first-in-class androgen receptor (AR) degrader • Updating on exclusive pipeline for the discovery of molecular gluesRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.